Combined Screening with PLGF (Delfia) + Hemoglobinopathy by HPLC
Test Overview
Combined Screening with PLGF (Delfia) + Hemoglobinopathy by HPLC is an advanced prenatal screening test performed during the first trimester of pregnancy. It assesses the risk of chromosomal abnormalities in the fetus and screens for inherited hemoglobin disorders.
What Does the Test Include?
✔ Combined Screening with PLGF (Delfia)
- Free β-hCG
- PAPP-A
- PLGF (Placental Growth Factor)
- Maternal age assessment
- Ultrasound findings (NT measurement)
✔ Hemoglobinopathy Screening by HPLC
- Detects abnormal hemoglobin variants
- Screens for conditions such as:
- Thalassemia
- Sickle Cell Disease
- Hemoglobin E and other variants
Why is this Test Important?
✅ Early assessment of fetal chromosomal abnormality risk
✅ Improved screening performance with PLGF inclusion
✅ Identifies carriers of inherited blood disorders
✅ Supports informed pregnancy management and genetic counseling
✅ Non-invasive and safe for both mother and baby
Recommended For
- Pregnant women in the first trimester (11–13 weeks + 6 days)
- Couples with a family history of thalassemia or hemoglobin disorders
- Women seeking comprehensive prenatal screening
Sample Required
Advanced BioCare Laboratories
Accurate Prenatal & Genetic Screening for a Healthier Pregnancy Journey.
#Dermafact #gynofact #PrenatalScreening #PLGF #CombinedScreening #Hemoglobinopathy #HPLC #ThalassemiaScreening #PregnancyCare #AdvancedBioCareLaboratories
